Agilis Chief Commercial Officer, Markus Peters, PhD, presented a talk entitled “Engineering Gene Therapies for Rare CNS Diseases” at the 10th Annual BioPharm America Conference in Boston. Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
• Multi-arm trial targets sub-population of advanced lung, and head and neck cancer patients Read More
Leading Diagnostics Executive Search Firm Fills Board of Directors Role for True Health Group Read More
The exclusive license agreement and research collaboration aims to advance gene-edited regulatory T-cell therapies for autoimmune disease. Read More
Aushon BioSystems (Aushon) and ABL, Inc. (ABL) today announced that ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis. Read More
Organogenesis Inc. has elevated two industry veterans and longtime company employees, Brian Grow and Patrick Bilbo, to Chief Commercial Officer and Chief Operating Officer, respectively. Read More
Agilis President & CEO Mark Pykett, VMD, PhD, presented a talk at the 12th Annual International Conference on Rare Disease and Orphan Drugs (ICORD) in Beijing, China. Read More